[
1. Tokito T, Azuma K, Yamada K, Naito Y, Matsuo N, Ishii H, et al. Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy. In Vivo. 2019;33(3):889-95. DOI: 10.21873/invivo.1155510.21873/invivo.11555655988531028213
]Search in Google Scholar
[
2. Chen Z, Wang Y, Fang M. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Cancer Med. 2020;9(4):1392-99. DOI: 10.1002/cam4.280910.1002/cam4.2809701307031881123
]Search in Google Scholar
[
3. Tetikkurt C, Yılmaz N, Tetikkurt S, Gundogdu Ş, Disci R. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions. Monaldi Arch Chest Dis. 2018;88(3):944. DOI: 10.4081/monaldi.2018.94410.4081/monaldi.2018.94430203633
]Search in Google Scholar
[
4. Nithin KU, Sridhar MG, Srilatha K, Habebullah S. CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding. Afr Health Sci. 2018;18(4):972-8. DOI: 10.4314/ahs.v18i4.1710.4314/ahs.v18i4.17635488730766562
]Search in Google Scholar
[
5. Gomes TA, Campos EA, Yoshida A, Sarian LO, Andrade LALA, Derchain SF. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers. Rev Bras Ginecol Obstet. 2020;42(9):555-61. DOI: 10.1055/s-0040-171299310.1055/s-0040-171299332992358
]Search in Google Scholar
[
6. Georgantzi K, Sköldenberg EG, Stridsberg M, Kogner P, Jakobson Å, Janson ET, et al. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. Pediatr Hematol Oncol. 2018;35(2):156-65. DOI: 10.1080/08880018.2018.146408710.1080/08880018.2018.146408729737901
]Search in Google Scholar
[
7. Qu T, Zhang J, Xu N, Liu B, Li M, Liu A, et al. Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer. Oncol Lett. 2019;17(5):4293-8. DOI: 10.3892/ol.2019.1007310.3892/ol.2019.10073644433130944623
]Search in Google Scholar
[
8. Yu RZ, Huang MT. [The Diagnostic Value of Tumor Markers Combined with Fiberoptic Bronchoscopic Brushing in Lung Carcinoma]. Labeled Immunoassays and Clinical Medicine. 2014;21:360-3.
]Search in Google Scholar
[
9. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138-43. DOI: 10.1016/j.lung-can.2011.11.012
]Search in Google Scholar
[
10. Villalobos P, Wistuba II. Lung Cancer Biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13-29. DOI: 10.1016/j.hoc.2016.08.00610.1016/j.hoc.2016.08.006513780427912828
]Search in Google Scholar
[
11. Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21(3):441-7. DOI: 10.1093/annonc/mdp33210.1093/annonc/mdp33219690057
]Search in Google Scholar
[
12. O’Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf). 2006;64(1):97-104. DOI: 10.1111/j.1365-2265.2005.02424.x10.1111/j.1365-2265.2005.02424.x16402936
]Search in Google Scholar
[
13. Ferreiro L, Toubes ME, Valdés L. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion]. Med Clin (Barc). 2015;145(4):171-7. DOI: 10.1016/j. medcli.2014.08.005
]Search in Google Scholar
[
14. Duffy MJ, O’Byrne K. Tissue and Blood Biomarkers in Lung Cancer: A Review. Adv Clin Chem. 2018;86:1-21. DOI: 10.1016/bs.acc.2018.05.00110.1016/bs.acc.2018.05.00130144837
]Search in Google Scholar
[
15. Allama AM, Abou-Elela DH, Ibrahim IM. Pleural and serum markers for diagnosis of malignant pleural effusion. Asian Cardiovasc Thorac Ann. 2020;28(9):560-5. DOI: 10.1177/021849232094831110.1177/021849232094831132741198
]Search in Google Scholar
[
16. Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17(1):74. DOI: 10.1186/s12967-019-1828-010.1186/s12967-019-1828-0640878430849967
]Search in Google Scholar
[
17. Hao C, Zhang G, Zhang L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:213-27. DOI: 10.1016/bs.pmbts.2018.12.01110.1016/bs.pmbts.2018.12.01130905451
]Search in Google Scholar
[
18. Osanyin GE, Okunade KS, Ayotunde Oluwole A. Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria. Hypertens Pregnancy. 2018;37(2):93-7. DOI: 10.1080/10641955.2018.146066710.1080/10641955.2018.146066729718786
]Search in Google Scholar
[
19. Chen C, Chen Q, Zhao Q, Liu M, Guo J. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Ann Clin Lab Sci. 2017;47(3):260-3.
]Search in Google Scholar
[
20. Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Asian Pac J Cancer Prev. 2014;15(22):9611-4. DOI: 10.7314/APJCP.2014.15.22.961110.7314/APJCP.2014.15.22.961125520076
]Search in Google Scholar
[
21. Ren X, Zhang Y, Lyu Y, Jin B, Guo H, Wu J, et al. Lac-tate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma. Cancer Biomark. 2019;26(2):139-50. DOI: 10.3233/CBM-19020110.3233/CBM-19020131356196
]Search in Google Scholar
